| Q37704772 | Anti-MDA5 antibodies in a large Mediterranean population of adults with dermatomyositis |
| Q37597693 | Chapter 1: The physiological role of lysyl tRNA synthetase in the immune system. |
| Q64053918 | Clinical Features and Cytokine Profile in Myositis Patients with Anti-EJ Autoantibodies Detected by a Novel Immunoprecipitation Assay |
| Q38497471 | Efficiency of a solid-phase chemiluminescence immunoassay for detection of antinuclear and cytoplasmic autoantibodies compared with gold standard immunoprecipitation |
| Q47685788 | Frequent occurrence of anti-tRNA(His) autoantibodies that recognize a conformational epitope in sera of patients with myositis |
| Q39762134 | High frequencies and co-existing of myositis-specific autoantibodies in patients with idiopathic inflammatory myopathies overlapped to rheumatoid arthritis |
| Q24523263 | Human immunodeficiency virus type 1 (HIV-1) viral protein R (Vpr) interacts with Lys-tRNA synthetase: implications for priming of HIV-1 reverse transcription |
| Q28910211 | Human lysyl-tRNA synthetase is secreted to trigger proinflammatory response |
| Q34824854 | Idiopathic inflammatory myopathy: autoantibody update |
| Q28343450 | Inosine and N1-methylinosine within a synthetic oligomer mimicking the anticodon loop of human tRNA(Ala) are major epitopes for anti-PL-12 myositis autoantibodies |
| Q35036195 | Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies |
| Q35309808 | Myositis-specific autoantibodies: detection and clinical associations |
| Q24804539 | Private specificities can dominate the humoral response to self-antigens in patients with cryptogenic fibrosing alveolitis |
| Q84600744 | [Antibodies in systemic autoimmune diseases. Special mention to systemic lupus erythematosus] |